Clinical Trials Directory

Trials / Terminated

TerminatedNCT00682552

Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Relationship between HPV infection and cervical cancer is well established. Among the HPV types identified to date, 15 are classified as high risk HPV (HR-HPV). Detection of HR-HPV has been proposed to optimize cervical cancer screening.

Detailed description

A prospective detection and quantification of HR-HPV in patients with proven CIN1 will be performed. Relationship between HR-HPV initial viral load and the CIN1 persistence will be evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDUREA cervico-vaginal cervical smear12 and 18 months after inclusion, a cervico-vaginal cervical smear will be realized and a new examination colposcopique with a new cervical taking for the search(research) and the detection of the HPV 16 and 18.

Timeline

Start date
2008-05-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2008-05-22
Last updated
2014-08-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00682552. Inclusion in this directory is not an endorsement.